Browse our anti-CMA1 (CMA1) Antibodies

Full name:
anti-Chymase 1, Mast Cell Antibodies (CMA1)
On are 97 Chymase 1, Mast Cell (CMA1) Antibodies from 20 different suppliers available. Additionally we are shipping CMA1 Kits (39) and CMA1 Proteins (25) and many more products for this protein. A total of 168 CMA1 products are currently listed.
chymase, CMA1, CYH, Mcp-5, MCP3P, Mcp5, Mcpt5, MCT1, MMCP-5

Most Popular Reactivities for anti-CMA1 (CMA1) Antibodies

Select your species and application

anti-Mouse (Murine) CMA1 Antibodies:

anti-Human CMA1 Antibodies:

anti-Rat (Rattus) CMA1 Antibodies:

All available anti-CMA1 Antibodies

Go to our pre-filtered search.

Top referenced anti-CMA1 Antibodies

  1. Dog (Canine) Polyclonal CMA1 Primary Antibody for IF (p), IHC (p) - ABIN679853 : Wang, Jessup, Zhao, Da Silva, Lin, MacNamara, Ahmad, Chappell, Ferrario, Groban: Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats. in PLoS ONE 2013 (PubMed)
    Show all 5 references for 679853

  2. Human Monoclonal CMA1 Primary Antibody for EIA, IHC (fro) - ABIN181829 : Buckley, McEuen, Walls: The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase. in The Journal of pathology 2000 (PubMed)

  3. Human Monoclonal CMA1 Primary Antibody for IHC (p), IHC - ABIN152116 : Hsieh, Sharma, Gibbons, Goggans, Erzurum, Haque: Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. in Proceedings of the National Academy of Sciences of the United States of America 2005 (PubMed)

  4. Human Polyclonal CMA1 Primary Antibody for ICC, IF - ABIN2506651 : Yan, Feng, Liu, Zhang, Dong, Liu, Cao, Mo, Li, Fang, Chen: Vagal afferents mediate antinociception of estrogen in a rat model of visceral pain: the involvement of intestinal mucosal mast cells and 5-hydroxytryptamine 3 signaling. in The journal of pain : official journal of the American Pain Society 2014 (PubMed)

More Antibodies against CMA1 Interaction Partners

Mouse (Murine) Chymase 1, Mast Cell (CMA1) interaction partners

  1. Mast cells have the ability to produce and degrade FXIIIA depending on their chymase expression profile: mast cells expressing chymase degrade FXIIIA, whereas mast cells that do not express chymase mainly produce FXIIIA

  2. Fibronectin (show FN1 Antibodies) was identified as a target of mMCP-5, and the exocytosis of mMCP-5 from the MCs (show SMCP Antibodies) in the mouse's peritoneal cavity resulted in the expression of metalloproteinase protease-9, which has been implicated in arthritis.

  3. Data indicate that a second-degree burn injury can initiate an immediate novel zonal degranulation of mast cell throughout all skin layers and a disruption of the epidermal tight junctions dependent on the nonredundant presence of mMCP4 and mMCP5.

  4. mast cell/chymase-mediated intestinal epithelial barrier function is mediated by proteinase-activated receptor 2 (show F2RL1 Antibodies)/MMP (show MMP2 Antibodies)-2 (show MMP2 Antibodies)-dependent

  5. mMCP-4-deficient mice but not to mMCP-5-deficient mice revealing nonredundant actions for these two MC proteases in a model of innate inflammatory injury with remodeling.

  6. mast cell mMCP-4, -5, and -6 (chymase and tryptase (show TPSAB1 Antibodies)) participate in the acute inflammation and remodeling process of viral myocarditis.

  7. The prominent mast cell secretory granule protease MCP-5 is essential for the occurrence of irreversible ischemia-reperfusion injury of skeletal muscle.

  8. mast cell chymase activates ERK (show EPHB2 Antibodies) and p38 (show CRK Antibodies) probably through G-protein-coupled receptor (show GPR34 Antibodies), and the ERK (show EPHB2 Antibodies) but not p38 (show CRK Antibodies) cascade may have a crucial role in chymase-induced migration of eosinophils

  9. chymase rapidly cleaves recombinant pro-IL-18 (show IL18 Antibodies) at 56-phenylalanine and produces a biologically active IL-18 (show IL18 Antibodies) fragment that is smaller than any other reported IL-18 (show IL18 Antibodies)-derived species

  10. Just after stopping the angiotensin II infusion, aortic ACE (show ACE Antibodies) and chymase activities were significantly increased, and were involved in the progression of aortic abdominal aneurysms

Human Chymase 1, Mast Cell (CMA1) interaction partners

  1. Cleavage of the alarmins by Human mast cell chymase and human neutrophil cathepsin G (show CTSG Antibodies) suggests a function in regulating excessive inflammation.

  2. activation of endothelial CLP (show CALML3 Antibodies)/chymase may directly relate to the increased inflammatory phenotypic changes in the vascular system in women with preeclampsia

  3. Placenta-derived chymotrypsin-like protease contributes to the altered endothelial barrier function in preeclampsia.

  4. Our data demonstrated that mast cell chymase plays an important role in keloid formation through TGF-beta1 (show TGFB1 Antibodies)/Smad (show SMAD1 Antibodies) signaling pathway.

  5. These data suggest a possible contribution of human chymase activation to LPS (show IRF6 Antibodies)-induced mortality

  6. we present data indicating that MC tryptase (show TPSAB1 Antibodies) and chymase contribute to the development of OSF (show OSTF1 Antibodies) and malignant transformation of the overlying epithelium.

  7. The polymorphisms and haplotypes of the CMA1 locus are associated with cardiac hypertrophy in male patients with symptomatic aortic stenosis.

  8. CMA1 gene single nucleotide polymorphisms is associated with essential hypertension.

  9. Significant association between the AG genotype of CMA1 A polymorphism and Angina Pectoris and Ventricular Extrasystoles was observed.

  10. demonstrate the generation of Pso (show PIPOX Antibodies) p27 (show PAK2 Antibodies) from SCCA1 with extracts from psoriatic scale and even more remarkably, the generation of Pso (show PIPOX Antibodies) p27 (show PAK2 Antibodies) from SCCA1 in the presence of mast cell associated chymase

CMA1 Antigen Profile

Antigen Summary

This gene product is a chymotryptic serine proteinase that belongs to the peptidase family S1. It is expressed in mast cells and thought to function in the degradation of the extracellular matrix, the regulation of submucosal gland secretion, and the generation of vasoactive peptides. In the heart and blood vessels, this protein, rather than angiotensin converting enzyme, is largely responsible for converting angiotensin I to the vasoactive peptide angiotensin II. Angiotensin II has been implicated in blood pressure control and in the pathogenesis of hypertension, cardiac hypertrophy, and heart failure. Thus, this gene product is a target for cardiovascular disease therapies. This gene maps to 14q11.2 in a cluster of genes encoding other proteases.

Alternative names and synonyms associated with CMA1

  • chymase 1, mast cell (CMA1) antibody
  • chymase 1, mast cell (Cma1) antibody
  • chymase antibody
  • CMA1 antibody
  • CYH antibody
  • Mcp-5 antibody
  • MCP3P antibody
  • Mcp5 antibody
  • Mcpt5 antibody
  • MCT1 antibody
  • MMCP-5 antibody

Protein level used designations for CMA1

chymase 1, mast cell , alpha-chymase , chymase , mast cell chymase 1 , mast cell protease 5 , mast cell protease I , chymase 1 preproprotein transcript E , chymase 1 preproprotein transcript I , chymase, heart , chymase, mast cell , mast cell protease 3 , mast cell protease III , rMCP-3 , rMCP-5 , rMCP-III , mast cell chymase , serine protease

540321 Bos taurus
745533 Pan troglodytes
100139881 Bos taurus
17228 Mus musculus
1215 Homo sapiens
25627 Rattus norvegicus
100135503 Cavia porcellus
490628 Canis lupus familiaris
Selected quality suppliers for anti-CMA1 (CMA1) Antibodies
Did you look for something else?